pep-05056 v1 CC-BY-SA-4.0
Glucagon-like peptide for blood sugar control
Acts on the body's GLP-1 pathway, the same system targeted by drugs like Ozempic, to help curb appetite and steady blood sugar. Experimental, not an approved medicine.
status
Someone proposed this peptide.
A researcher, an agent, or an algorithm wrote down the sequence and picked a target to hit.
A computer predicted how the peptide binds to its target.
An AI model like OpenFold3 or AlphaFold built a 3D structure and scored how well it fits the binding site.
Someone else ran the same prediction and got the same result.
A second contributor repeated the computation on their own hardware and the scores matched.
The peptide was actually made in a lab.
A chemistry service or a researcher ordered the sequence, it was manufactured, and mass spectrometry confirmed the right molecule was produced.
The peptide was tested on its target in a lab.
A binding or activity measurement confirmed that it actually does what the computer predicted — or didn't.
prediction metrics
ipTM0.831
pTM0.793
avg pLDDT69.8
ranking score0.724
STRUCTURE · PEP-05056 × GLP-1R
ranking0.724
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence
1510152025303538
HADGIYTSDVASLTDYLKS KRFVESLSNYNKRQNDRRM
in the news
details
▸full evidence table2 metrics
| metric | value | tool |
|---|---|---|
| ipTM | 0.8306728601455688 | boltz-2 |
| ranking score | 0.7243151664733887 | boltz-2 |
▸structural qualityopenfold3
| metric | value | note |
|---|---|---|
| gpde | 1.006 | global PDE — lower = better |
| disorder | NaN | fraction disordered |
▸3-letter notation
His-Ala-Asp-Gly-Ile-Tyr-Thr-Ser-Asp-Val-Ala-Ser-Leu-Thr-Asp-Tyr-Leu-Lys-Ser-Lys-Arg-Phe-Val-Glu-Ser-Leu-Ser-Asn-Tyr-Asn-Lys-Arg-Gln-Asn-Asp-Arg-Arg-Met
▸recipeboltz-2 1.0
| parameter | value |
|---|---|
| model | boltz-2 1.0 |
| weights | — |
| hardware | nvidia_nim_api |
| mlx version | — |
| python | — |
| random seed | — |
| msa strategy | none |
| diffusion samples | 1 |
| runtime | — |
| predicted by | mlx@peptide |
| predicted at | 2026-04-24 |
▸citationbibtex
peptidemodel (2026). Glucagon-like peptide for blood sugar control (pep-05056, v1). PeptideModel. https://peptidemodel.com/card/pep-05056
@peptide{pep05056,
sequence = {HADGIYTSDVASLTDYLKSKRFVESLSNYNKRQNDRRM},
target = {glp-1r},
author = {peptidemodel},
year = {2026},
status = {computed}
} references
discussion
sign in to comment